This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration. Need a new registration confirmation email? Click here
Mead Johnson Nutrition (MJN)
Q1 2012 Earnings Call
April 26, 2012 9:30 am ET
Kathy Ann MacDonald - Acting Corporate Controller and Vice President of Investor Relations
Stephen W. Golsby - Chief Executive Officer, President and Director
Peter Kasper Jakobsen - President of Americas Operations
Peter G. Leemputte - Chief Financial Officer and Executive Vice President
Matthew C. Grainger - Morgan Stanley, Research Division
Edward Aaron - RBC Capital Markets, LLC, Research Division
Varun Gokarn - Goldman Sachs Group Inc., Research Division
Timothy S. Ramey - D.A. Davidson & Co., Research Division
Jon Andersen - William Blair & Company L.L.C., Research Division
Leigh Ferst - Wellington Shields & Co., LLC, Research Division
Robert Moskow - Crédit Suisse AG, Research Division
Alexis Borden - Citigroup Inc, Research Division
Good day, ladies and gentlemen, and welcome to the Mead Johnson Nutrition First Quarter 2012 Earnings Conference Call. My name is Shikwana, and I will be your coordinator for today. [Operator Instructions] I would Now like to turn the presentation over to Kathy MacDonald, Vice President, Investor Relations. Please proceed, Kathy.
Kathy Ann MacDonald
Thank you, and good morning. Welcome to Mead Johnson's first quarter conference call. Speaking today will be Steve Golsby, our Chief Executive Officer; Pete Leemputte, our Chief Financial Officer; and Kasper Jakobsen, our recently appointed Chief Operating Officer.
Before we get started, let me remind you that our comments will include forward-looking statements about our future results, including statements about our financial prospects and projections, new product launches and market conditions, that constitute forward-looking statements for purposes of the Safe Harbor provision under the Private Securities Litigation Reform Act of 1995.